-
Deniz Bruce, CEO of GMDN Agency
News
Common Coding brings Clarity to Medical Device Regulations
Aug 01 2023
The Global Medical Device Nomenclature (GMDN) has joined forces with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to strengthen the functionality of the MHRA's Public Access Registration Database (PARD), a significant development for medical device regulation that will improve patient safety, streamline the classification, promote transparency and enhance accessibility to vital medical device information.
By incorporating GMDN Codes into PARD, the MHRA ensures a common language and coding system that fosters seamless communication between regulatory bodies, manufacturers, healthcare professionals, and patients. It will also strengthen the MHRA's post-market surveillance capabilities enabling efficient tracking and analysis of adverse events, product recalls and safety concerns. The standardised coding system also enables rapid identification of specific device types, allowing the MHRA to take timely regulatory actions to ensure patient safety and maintain the integrity of the market.
Dr Laura Squire, MHRA Chief Healthcare Quality & Access Officer, said: “Our work with GMDN Agency to strengthen PARD will give us better data about medical devices on the market and enable us to improve our understanding of their relative safety and performance. More consistent data across MHRA systems and the wider health and social care system will be to the benefit of patients and users of medical devices.”
Another key benefit of incorporating GMDN Codes into PARD is the standardised classification of medical devices. Manufacturers registering their devices in PARD can easily select the appropriate GMDN Code that accurately represents the device's intended use and attributes. This significantly reduces errors, simplifies the registration process and saves valuable time for all stakeholders involved.
Deniz Bruce, CEO of the GMDN Agency, said, "We are delighted to collaborate with the MHRA in their pursuit of enhancing medical device regulation. The integration of GMDN within PARD will streamline processes and facilitate effective communication, ultimately promoting patient safety."
Moreover, this collaboration fosters harmonisation with international standards as GMDN Codes are widely accepted and used by more than 70 regulatory authorities worldwide.
More information online
Digital Edition
Lab Asia Dec 2025
December 2025
Chromatography Articles- Cutting-edge sample preparation tools help laboratories to stay ahead of the curveMass Spectrometry & Spectroscopy Articles- Unlocking the complexity of metabolomics: Pushi...
View all digital editions
Events
Jan 21 2026 Tokyo, Japan
Jan 28 2026 Tokyo, Japan
Jan 29 2026 New Delhi, India
Feb 07 2026 Boston, MA, USA
Asia Pharma Expo/Asia Lab Expo
Feb 12 2026 Dhaka, Bangladesh



